Home›Clinical trials›Washington

GLP-1 clinical trials in Washington: 24 recruiting now

36 sites in 10 Washington cities. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (5)

Weight-loss study of orforglipron

Where: Seattle and Tacoma

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.

Free to join

Who can join: Children and teens 6 to 17 with obesity.

Call the site: 425-786-3784Study record on ClinicalTrials.gov

Seattle Children's Research Institute - Hughes Building - PIN, Seattle. 425-786-3784

MultiCare Health System - Mary Bridge Children's Health Center, Tacoma. 253-403-0776

Weight-loss study of semaglutide

Where: Renton and Seattle

What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.

Free to join

Who can join: Adults 18+ who are overweight.

Study record on ClinicalTrials.gov

Rainier Clin Res Ctr Inc, Renton

Seattle Clinical Research Center, Seattle

Weight-loss study of tirzepatide

Where: Seattle and Tacoma

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.

Free to join

Who can join: Children and teens 6 to 11 with obesity.

Call the site: 425-786-3784Study record on ClinicalTrials.gov

Seattle Children's Research Institute - Hughes Building - PIN, Seattle. 425-786-3784

MultiCare Health System - Mary Bridge Children's Health Center, Tacoma. 253-403-0776

Show 2 more studies

Weight-loss study of maridebart cafraglutide

Where: Redmond

What: Tests whether a study medicine from Amgen, Maridebart Cafraglutide, can help people lose weight.

Free to join

Who can join: Adults 18+ with obesity or overweight, BMI 25+.

Study record on ClinicalTrials.gov

Eastside Research Associates Health Research, Redmond

Weight-loss study of LY3305677

Where: Wenatchee

What: Tests whether an investigational medicine from Lilly, LY3305677, can help people lose weight.

Free to join

Who can join: Adults 18 to 75 with obesity, BMI 27+.

Call the site: 509-436-4050Study record on ClinicalTrials.gov

Central Washington Health Services Association d/b/a Confluence Health, Wenatchee. 509-436-4050

Type 2 diabetes studies (5)

Type 2 diabetes study of semaglutide

Where: Renton and Seattle

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Study record on ClinicalTrials.gov

Research Site, Renton

Research Site, Seattle

Type 2 diabetes study of cagrisema

Where: Seattle

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Children and teens 10 to 18 with type 2 diabetes.

Study record on ClinicalTrials.gov

Seattle Children's Research Institute, Seattle

Type 2 diabetes study of survodutide

Where: Redmond

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

ERA Health Research - Redmond, Redmond. 833-602-2368

Show 2 more studies

Type 2 diabetes study of UBT251

Where: Vancouver

What: Tests whether an investigational medicine from Novo Nordisk, UBT251, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18 to 75 with type 2 diabetes.

Study record on ClinicalTrials.gov

The Vancouver Clinic, Vancouver

Other GLP-1 studies in Washington (14)

Fatty liver disease (MASLD) study of retatrutide

Where: Bellevue, Seattle and Tacoma

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Call the site: 425-454-4768Study record on ClinicalTrials.gov

Washington Gastroenterology - Bellevue, Bellevue. 425-454-4768

UW Medicine Diabetes Institute, Seattle

Washington Gastroenterology - Tacoma, Tacoma. 253-272-5127

Fatty liver disease with liver scarring study of survodutide

Where: Seattle and Spokane

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Velocity Clinical Research, Seattle, Seattle. 833-602-2368

Velocity Clinical Research-Spokane-69716, Spokane. 833-602-2368

Fatty liver disease (also called MASH or NASH) study of survodutide

Where: Seattle and Spokane

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Velocity Clinical Research, Seattle, Seattle. 833-602-2368

Velocity Clinical Research-Spokane-69716, Spokane. 833-602-2368

Show 11 more studies

Stress urinary incontinence (bladder leaks) study of orforglipron

Where: Bellevue and Seattle

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people reduce bladder leaks.

Free to join

Who can join: Adults 18+, women only with stress urinary incontinence (bladder leaks), BMI 27+.

Call the site: 877-453-0404Study record on ClinicalTrials.gov

Northwest Clinical Research Center, Bellevue. 877-453-0404

Seattle Clinical Research Center, Seattle. 206-522-3330

Peripheral artery disease study of orforglipron

Where: Lynnwood and Redmond

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people improve blood flow in the legs.

Free to join

Who can join: Adults 18+ with peripheral artery disease (poor blood flow in the legs), BMI 23+.

Call the site: 425-869-6828Study record on ClinicalTrials.gov

ERA Health Research - CardioNow - Lynnwood, Lynnwood. 425-869-6828

Eastside Research Associates, Redmond. 425-869-6828

Type 1 diabetes study of semaglutide

Where: Seattle

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 1 diabetes lower blood sugar.

Free to join

Who can join: Adults 18 to 49 with type 1 diabetes, BMI 20+.

Call the site: 504-521-7822Study record on ClinicalTrials.gov

University of Washington Medicine Diabetes Institute (UWMDI), Seattle. 504-521-7822

Ulcerative colitis study of tirzepatide

Where: Tacoma

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.

Free to join

Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.

Call the site: 253-272-5127Study record on ClinicalTrials.gov

Washington Gastroenterology - Tacoma, Tacoma. 253-272-5127

Crohn's disease study of tirzepatide

Where: Tacoma

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.

Free to join

Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.

Call the site: 253-272-5127Study record on ClinicalTrials.gov

Washington Gastroenterology - Tacoma, Tacoma. 253-272-5127

Stroke (CVA) or transient ischemic attack study of semaglutide

Where: Seattle

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 40 to 65 with type 2 diabetes.

Call the site: 206-744-8305Study record on ClinicalTrials.gov

University of Washington - Harborview Medical Center, Seattle. 206-744-8305

Diabetic kidney disease study of semaglutide

Where: Seattle and Spokane

What: Tests whether a GLP-1 medicine, semaglutide, can help people with diabetic kidney disease protect their kidneys.

Free to join

Who can join: Adults 18+ with diabetic kidney disease, BMI 20+.

Call the site: 425-624-7899Study record on ClinicalTrials.gov

University of Washington, Seattle. 425-624-7899

Providence Sacred Heart Medical Center, Spokane. 509-474-5313

Chronic kidney disease study of NNC0519-0130

Where: Spokane

What: Tests whether an investigational medicine from Novo Nordisk, NNC0519-0130, can help people with chronic kidney disease protect their kidneys.

Free to join

Who can join: Adults 18+ with chronic kidney disease, BMI 27+.

Study record on ClinicalTrials.gov

Providence Medical Research Center, Spokane

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Clinical trials by state

Every state with a GLP-1 study recruiting today. 48 of them.

Written and edited by GLP ChartAbout this siteContact
Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.